![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ME3 |
Gene summary for ME3 |
![]() |
Gene information | Species | Human | Gene symbol | ME3 | Gene ID | 10873 |
Gene name | malic enzyme 3 | |
Gene Alias | NADP-ME | |
Cytomap | 11q14.2 | |
Gene Type | protein-coding | GO ID | GO:0006082 | UniProtAcc | Q16798 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10873 | ME3 | male-WTA | Human | Thyroid | PTC | 3.36e-07 | 1.03e-01 | 0.1037 |
10873 | ME3 | PTC01 | Human | Thyroid | PTC | 5.59e-05 | 7.20e-02 | 0.1899 |
10873 | ME3 | PTC04 | Human | Thyroid | PTC | 1.39e-05 | 1.22e-01 | 0.1927 |
10873 | ME3 | PTC06 | Human | Thyroid | PTC | 1.09e-09 | 3.08e-01 | 0.2057 |
10873 | ME3 | PTC07 | Human | Thyroid | PTC | 7.76e-10 | 1.49e-01 | 0.2044 |
10873 | ME3 | ATC09 | Human | Thyroid | ATC | 2.33e-04 | 3.04e-01 | 0.2871 |
10873 | ME3 | ATC12 | Human | Thyroid | ATC | 1.58e-03 | 1.02e-01 | 0.34 |
10873 | ME3 | ATC1 | Human | Thyroid | ATC | 1.57e-04 | 3.54e-01 | 0.2878 |
10873 | ME3 | ATC2 | Human | Thyroid | ATC | 1.12e-18 | 1.14e+00 | 0.34 |
10873 | ME3 | ATC4 | Human | Thyroid | ATC | 9.88e-04 | 1.40e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000914526 | Thyroid | PTC | purine nucleoside triphosphate biosynthetic process | 41/5968 | 69/18723 | 2.17e-06 | 2.91e-05 | 41 |
GO:000913225 | Thyroid | PTC | nucleoside diphosphate metabolic process | 64/5968 | 124/18723 | 3.80e-06 | 4.78e-05 | 64 |
GO:000920626 | Thyroid | PTC | purine ribonucleoside triphosphate biosynthetic process | 40/5968 | 68/18723 | 4.11e-06 | 5.11e-05 | 40 |
GO:000675325 | Thyroid | PTC | nucleoside phosphate metabolic process | 205/5968 | 497/18723 | 5.24e-06 | 6.35e-05 | 205 |
GO:000911725 | Thyroid | PTC | nucleotide metabolic process | 202/5968 | 489/18723 | 5.46e-06 | 6.60e-05 | 202 |
GO:000914226 | Thyroid | PTC | nucleoside triphosphate biosynthetic process | 46/5968 | 85/18723 | 1.76e-05 | 1.83e-04 | 46 |
GO:0046939110 | Thyroid | PTC | nucleotide phosphorylation | 52/5968 | 101/18723 | 3.25e-05 | 3.08e-04 | 52 |
GO:000920120 | Thyroid | PTC | ribonucleoside triphosphate biosynthetic process | 40/5968 | 74/18723 | 6.30e-05 | 5.53e-04 | 40 |
GO:000915224 | Thyroid | PTC | purine ribonucleotide biosynthetic process | 78/5968 | 169/18723 | 6.88e-05 | 6.01e-04 | 78 |
GO:0006165110 | Thyroid | PTC | nucleoside diphosphate phosphorylation | 50/5968 | 99/18723 | 8.68e-05 | 7.22e-04 | 50 |
GO:004639024 | Thyroid | PTC | ribose phosphate biosynthetic process | 85/5968 | 190/18723 | 1.30e-04 | 1.03e-03 | 85 |
GO:000926024 | Thyroid | PTC | ribonucleotide biosynthetic process | 81/5968 | 182/18723 | 2.27e-04 | 1.65e-03 | 81 |
GO:000609020 | Thyroid | PTC | pyruvate metabolic process | 51/5968 | 106/18723 | 3.47e-04 | 2.39e-03 | 51 |
GO:007252219 | Thyroid | PTC | purine-containing compound biosynthetic process | 86/5968 | 200/18723 | 5.85e-04 | 3.72e-03 | 86 |
GO:000616419 | Thyroid | PTC | purine nucleotide biosynthetic process | 81/5968 | 191/18723 | 1.35e-03 | 7.65e-03 | 81 |
GO:00460395 | Thyroid | PTC | GTP metabolic process | 15/5968 | 25/18723 | 3.45e-03 | 1.67e-02 | 15 |
GO:000906033 | Thyroid | ATC | aerobic respiration | 126/6293 | 189/18723 | 1.21e-20 | 2.02e-18 | 126 |
GO:000609134 | Thyroid | ATC | generation of precursor metabolites and energy | 256/6293 | 490/18723 | 6.55e-18 | 7.69e-16 | 256 |
GO:004533333 | Thyroid | ATC | cellular respiration | 140/6293 | 230/18723 | 1.76e-17 | 1.89e-15 | 140 |
GO:001598034 | Thyroid | ATC | energy derivation by oxidation of organic compounds | 177/6293 | 318/18723 | 3.60e-16 | 2.92e-14 | 177 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ME3 | SNV | Missense_Mutation | novel | c.990N>A | p.His330Gln | p.H330Q | Q16798 | protein_coding | tolerated(0.5) | possibly_damaging(0.552) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ME3 | SNV | Missense_Mutation | c.121N>A | p.Ala41Thr | p.A41T | Q16798 | protein_coding | tolerated(0.53) | benign(0.003) | TCGA-BH-A0DG-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
ME3 | SNV | Missense_Mutation | novel | c.1081G>A | p.Glu361Lys | p.E361K | Q16798 | protein_coding | deleterious(0.04) | benign(0.162) | TCGA-C8-A12Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
ME3 | SNV | Missense_Mutation | c.724N>G | p.Leu242Val | p.L242V | Q16798 | protein_coding | deleterious(0.01) | benign(0.255) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD | |
ME3 | SNV | Missense_Mutation | c.431N>T | p.Ala144Val | p.A144V | Q16798 | protein_coding | deleterious(0.01) | possibly_damaging(0.855) | TCGA-D8-A1XC-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
ME3 | insertion | Nonsense_Mutation | novel | c.682_683insAGAGAAATGTTAAAAATAAGATATCAGCCACATAACAAGCACTAAT | p.Leu228GlnfsTer12 | p.L228Qfs*12 | Q16798 | protein_coding | TCGA-AN-A049-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ME3 | SNV | Missense_Mutation | novel | c.1108N>A | p.Asp370Asn | p.D370N | Q16798 | protein_coding | deleterious(0.03) | possibly_damaging(0.654) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
ME3 | SNV | Missense_Mutation | rs369256814 | c.590N>C | p.Leu197Pro | p.L197P | Q16798 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A6-6138-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ME3 | SNV | Missense_Mutation | c.446G>A | p.Gly149Asp | p.G149D | Q16798 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-AA-3819-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ME3 | SNV | Missense_Mutation | c.988C>A | p.His330Asn | p.H330N | Q16798 | protein_coding | tolerated(0.45) | benign(0.076) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
10873 | ME3 | ENZYME | DHT | ANDROSTANOLONE | 1811987 | |
10873 | ME3 | ENZYME | ASPIRIN | ASPIRIN | 8611656 | |
10873 | ME3 | ENZYME | GLUTACONATE | GLUTACONATE | 19595601 | |
10873 | ME3 | ENZYME | MALEIC ACID | MALEIC ACID | 19595601 | |
10873 | ME3 | ENZYME | MALONIC ACID | MALONIC ACID | 19595601 |
Page: 1 |